Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant Therapy

Joel M. Baumgartner, Alyssa Krasinskas, Mustapha Daouadi, Amer Zureikat, Wallis Marsh, Kenneth Lee, David Bartlett, A. James Moser, Herbert J. Zeh

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: Celiac trunk encasement by adenocarcinoma of the pancreatic body is generally regarded as a contraindication for surgical resection. Recent studies have suggested that a subset of stage III patients will succumb to their disease in the absence of distant metastases. We hypothesized that patients with stage III tumors invading the celiac trunk, who are free of distant disease following neoadjuvant therapy, may derive prolonged survival benefit from aggressive surgical resection. Methods: We performed a retrospective review of distal pancreatectomies with en bloc celiac axis resection for pancreatic adenocarcinoma. Results: Eleven patients underwent a distal pancreatectomy with en bloc celiac axis resection after completing neoadjuvant chemoradiation therapy. Median operative time was 8 h, 14 min, and median estimated blood loss was 700 ml. Median length of stay was 9 days. Five patients (45%) had postoperative complications; three were Clavien grade I. Four patients (35%) had pancreatic leaks; two were ISGPF grade B, and two were grade A. There were two 90-day perioperative deaths. Ten patients had R0 resections (91%). After a median follow-up of 41 weeks, six patients recurred. Four of the five patients with SMAD4 loss recurred, and two of the five patients with intact SMAD4 recurred. Median disease-free and overall survival were 21 weeks and 26 months, respectively. Conclusions: Resection of pancreatic body adenocarcinoma with celiac axis resection is technically feasible with acceptable perioperative morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)1152-1159
Number of pages8
JournalJournal of Gastrointestinal Surgery
Volume16
Issue number6
DOIs
StatePublished - Jun 1 2012
Externally publishedYes

Fingerprint

Pancreatectomy
Neoadjuvant Therapy
Abdomen
Adenocarcinoma
Operative Time
Disease-Free Survival
Length of Stay
Neoplasm Metastasis
Morbidity
Survival
Mortality

Keywords

  • Appleby
  • Celiac artery resection
  • Neoadjuvant therapy
  • Pancreatic cancer

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology

Cite this

Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant Therapy. / Baumgartner, Joel M.; Krasinskas, Alyssa; Daouadi, Mustapha; Zureikat, Amer; Marsh, Wallis; Lee, Kenneth; Bartlett, David; Moser, A. James; Zeh, Herbert J.

In: Journal of Gastrointestinal Surgery, Vol. 16, No. 6, 01.06.2012, p. 1152-1159.

Research output: Contribution to journalArticle

Baumgartner, Joel M. ; Krasinskas, Alyssa ; Daouadi, Mustapha ; Zureikat, Amer ; Marsh, Wallis ; Lee, Kenneth ; Bartlett, David ; Moser, A. James ; Zeh, Herbert J. / Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant Therapy. In: Journal of Gastrointestinal Surgery. 2012 ; Vol. 16, No. 6. pp. 1152-1159.
@article{68f469cc2d624c6197984ccfda5be753,
title = "Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant Therapy",
abstract = "Background: Celiac trunk encasement by adenocarcinoma of the pancreatic body is generally regarded as a contraindication for surgical resection. Recent studies have suggested that a subset of stage III patients will succumb to their disease in the absence of distant metastases. We hypothesized that patients with stage III tumors invading the celiac trunk, who are free of distant disease following neoadjuvant therapy, may derive prolonged survival benefit from aggressive surgical resection. Methods: We performed a retrospective review of distal pancreatectomies with en bloc celiac axis resection for pancreatic adenocarcinoma. Results: Eleven patients underwent a distal pancreatectomy with en bloc celiac axis resection after completing neoadjuvant chemoradiation therapy. Median operative time was 8 h, 14 min, and median estimated blood loss was 700 ml. Median length of stay was 9 days. Five patients (45{\%}) had postoperative complications; three were Clavien grade I. Four patients (35{\%}) had pancreatic leaks; two were ISGPF grade B, and two were grade A. There were two 90-day perioperative deaths. Ten patients had R0 resections (91{\%}). After a median follow-up of 41 weeks, six patients recurred. Four of the five patients with SMAD4 loss recurred, and two of the five patients with intact SMAD4 recurred. Median disease-free and overall survival were 21 weeks and 26 months, respectively. Conclusions: Resection of pancreatic body adenocarcinoma with celiac axis resection is technically feasible with acceptable perioperative morbidity and mortality.",
keywords = "Appleby, Celiac artery resection, Neoadjuvant therapy, Pancreatic cancer",
author = "Baumgartner, {Joel M.} and Alyssa Krasinskas and Mustapha Daouadi and Amer Zureikat and Wallis Marsh and Kenneth Lee and David Bartlett and Moser, {A. James} and Zeh, {Herbert J.}",
year = "2012",
month = "6",
day = "1",
doi = "10.1007/s11605-012-1839-0",
language = "English (US)",
volume = "16",
pages = "1152--1159",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Distal Pancreatectomy with En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Adenocarcinoma Following Neoadjuvant Therapy

AU - Baumgartner, Joel M.

AU - Krasinskas, Alyssa

AU - Daouadi, Mustapha

AU - Zureikat, Amer

AU - Marsh, Wallis

AU - Lee, Kenneth

AU - Bartlett, David

AU - Moser, A. James

AU - Zeh, Herbert J.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Background: Celiac trunk encasement by adenocarcinoma of the pancreatic body is generally regarded as a contraindication for surgical resection. Recent studies have suggested that a subset of stage III patients will succumb to their disease in the absence of distant metastases. We hypothesized that patients with stage III tumors invading the celiac trunk, who are free of distant disease following neoadjuvant therapy, may derive prolonged survival benefit from aggressive surgical resection. Methods: We performed a retrospective review of distal pancreatectomies with en bloc celiac axis resection for pancreatic adenocarcinoma. Results: Eleven patients underwent a distal pancreatectomy with en bloc celiac axis resection after completing neoadjuvant chemoradiation therapy. Median operative time was 8 h, 14 min, and median estimated blood loss was 700 ml. Median length of stay was 9 days. Five patients (45%) had postoperative complications; three were Clavien grade I. Four patients (35%) had pancreatic leaks; two were ISGPF grade B, and two were grade A. There were two 90-day perioperative deaths. Ten patients had R0 resections (91%). After a median follow-up of 41 weeks, six patients recurred. Four of the five patients with SMAD4 loss recurred, and two of the five patients with intact SMAD4 recurred. Median disease-free and overall survival were 21 weeks and 26 months, respectively. Conclusions: Resection of pancreatic body adenocarcinoma with celiac axis resection is technically feasible with acceptable perioperative morbidity and mortality.

AB - Background: Celiac trunk encasement by adenocarcinoma of the pancreatic body is generally regarded as a contraindication for surgical resection. Recent studies have suggested that a subset of stage III patients will succumb to their disease in the absence of distant metastases. We hypothesized that patients with stage III tumors invading the celiac trunk, who are free of distant disease following neoadjuvant therapy, may derive prolonged survival benefit from aggressive surgical resection. Methods: We performed a retrospective review of distal pancreatectomies with en bloc celiac axis resection for pancreatic adenocarcinoma. Results: Eleven patients underwent a distal pancreatectomy with en bloc celiac axis resection after completing neoadjuvant chemoradiation therapy. Median operative time was 8 h, 14 min, and median estimated blood loss was 700 ml. Median length of stay was 9 days. Five patients (45%) had postoperative complications; three were Clavien grade I. Four patients (35%) had pancreatic leaks; two were ISGPF grade B, and two were grade A. There were two 90-day perioperative deaths. Ten patients had R0 resections (91%). After a median follow-up of 41 weeks, six patients recurred. Four of the five patients with SMAD4 loss recurred, and two of the five patients with intact SMAD4 recurred. Median disease-free and overall survival were 21 weeks and 26 months, respectively. Conclusions: Resection of pancreatic body adenocarcinoma with celiac axis resection is technically feasible with acceptable perioperative morbidity and mortality.

KW - Appleby

KW - Celiac artery resection

KW - Neoadjuvant therapy

KW - Pancreatic cancer

UR - http://www.scopus.com/inward/record.url?scp=84862826984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862826984&partnerID=8YFLogxK

U2 - 10.1007/s11605-012-1839-0

DO - 10.1007/s11605-012-1839-0

M3 - Article

C2 - 22399269

AN - SCOPUS:84862826984

VL - 16

SP - 1152

EP - 1159

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 6

ER -